PF-05221304 tromethamine
PF-05221304 tromethamine is an orally active, liver-directed and dual ACC1/ACC2 inhibitor with IC50s of 7.5 nM for rat ACC1, 8.2 nM for rat ACC2. PF-05221304 tromethamine is a substrate for organic anion transport polypeptides. PF-05221304 tromethamine directly improves a variety of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) pathogenic factors.
For research use only. We do not sell to patients.
- CAS No.: 2334472-62-5
- Formula: C32H41N5O8
- Molecular Weight:623.71
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
IC50: 7.5 nM for rat ACC1, 8.2 nM for rat ACC2[1]
PF-05221304 tromethamine inhibits hepatic de novo lipogenesis (DNL) with an IC50 of 61 nM in human hepatocytes (donor HH AA 508) in a concentration-dependent manner. PF-05221304 tromethamine stimulates fatty acid oxidation and reduces triglyceride accumulation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar Han rats[1]
-
Dosage:5 mg/kg
-
Administration:Oral administration; twice a day; 6 weeks
-
Result:Reduced the expression of these genes (a-SMA, Col1A1, Col3A1, CCL2 and CCL11) by 46% (P <0.01), 40% (P < 0.01), 44% (P < 0.05), 61% (P < .001) and 45% (P < .05), respectively.
Chemical Information
-
CAS No. 2334472-62-5
-
Molecular Weight 623.71
-
Formula C32H41N5O8
-
SMILES
O=C(O)C=1C=CC(=CC1)C2=NC(OC)=CC(=C2)C(=O)N3CCC4(CC(=O)C5=C(C=NN5C(C)C)C4)CC3.OCC(N)(CO)CO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)